Both in Pharmaceuticals
Xeris Biopharma Holdings vs Braveheart Bio
Over the past year XERS returned +43.8% and BRVE returned −19.3%; their daily moves had a correlation of 0.06.
XERS +43.8% BRVE −19.3%Growth of $1, one year, split-adjusted
| Metric | XERS | BRVE |
|---|---|---|
| Price | $10.71 | $21.51 |
| Market cap | $1.95B | $1.94B |
| Today | −0.37% | +1.51% |
| 1 month | +15.8% | +0.5% |
| 6 months | +70.5% | — |
| Year to date | +36.4% | — |
| 1 year | +11.3% | — |
| Revenue growth (YoY) | +28.7% | — |
| Gross margin | 86.4% | — |
| Net margin | −33.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.8× | — |
| Net cash | -$130.8M | — |
| Dividend yield | — | — |
| Volatility (60d) | 53.0% | — |
| Short % of float | 4.6% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).